Jacobson Pharma Corporation Limited (HKG:2633)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.260
0.00 (0.00%)
At close: Mar 10, 2026
5.88%
Market Cap 2.52B
Revenue (ttm) 1.53B
Net Income (ttm) 302.58M
Shares Out 2.00B
EPS (ttm) 0.15
PE Ratio 8.29
Forward PE 8.69
Dividend 0.10 (7.74%)
Ex-Dividend Date Dec 1, 2025
Volume 290,000
Average Volume 245,375
Open 1.280
Previous Close 1.260
Day's Range 1.250 - 1.280
52-Week Range 0.980 - 1.780
Beta 0.24
RSI 47.24
Earnings Date Feb 16, 2026

About HKG:2633

Jacobson Pharma Corporation Limited, through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally. It operates in two segments, Generic Drugs and Branded Healthcare. The company offers generic drugs for various therapeutic categories, including cardiovascular, central nervous, gastrointestinal, respiratory, musculo-skeletal, genito-urinary, anti-infectives, endocrine and metabolic, dermatological, and anti-allergic. It... [Read more]

Sector Healthcare
Founded 2016
Employees 1,792
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2633
Full Company Profile

Financial Performance

In fiscal year 2025, HKG:2633's revenue was 1.58 billion, an increase of 7.43% compared to the previous year's 1.47 billion. Earnings were 300.83 million, an increase of 12.69%.

Financial Statements

News

There is no news available yet.